ID   F262_HUMAN              Reviewed;         505 AA.
AC   O60825; O60824; Q5VVQ3; Q5VVQ4; Q9H3P1;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 2.
DT   28-JUN-2023, entry version 209.
DE   RecName: Full=6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 {ECO:0000305};
DE            Short=6PF-2-K/Fru-2,6-P2ase 2;
DE            Short=PFK/FBPase 2;
DE   AltName: Full=6PF-2-K/Fru-2,6-P2ase heart-type isozyme;
DE   Includes:
DE     RecName: Full=6-phosphofructo-2-kinase;
DE              EC=2.7.1.105 {ECO:0000269|PubMed:11069105};
DE   Includes:
DE     RecName: Full=Fructose-2,6-bisphosphatase;
DE              EC=3.1.3.46 {ECO:0000269|PubMed:11069105};
GN   Name=PFKFB2 {ECO:0000312|HGNC:HGNC:8873};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=9652401; DOI=10.1046/j.1432-1327.1998.2540103.x;
RA   Heine-Suner D., Diaz-Guillen M.A., Lange A.J., Rodriguez de Cordoba S.;
RT   "Sequence and structure of the human 6-phosphofructo-2-kinase/fructose-2,6-
RT   bisphosphatase heart isoform gene (PFKFB2).";
RL   Eur. J. Biochem. 254:103-110(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=11374908; DOI=10.1006/geno.2001.6527;
RA   Soejima H., Kawamoto S., Akai J., Miyoshi O., Arai Y., Morohka T.,
RA   Matsuo S., Niikawa N., Kimura A., Okubo K., Mukai T.;
RT   "Isolation of novel heart-specific genes using the BodyMap database.";
RL   Genomics 74:115-120(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Matsutani A.;
RT   "Human insulinoma PFK2/F26DPase.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION AT SER-466, MUTAGENESIS OF SER-466, CATALYTIC ACTIVITY,
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11069105; DOI=10.1016/s0960-9822(00)00742-9;
RA   Marsin A.S., Bertrand L., Rider M.H., Deprez J., Beauloye C., Vincent M.F.,
RA   Van den Berghe G., Carling D., Hue L.;
RT   "Phosphorylation and activation of heart PFK-2 by AMPK has a role in the
RT   stimulation of glycolysis during ischaemia.";
RL   Curr. Biol. 10:1247-1255(2000).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; THR-468; SER-483 AND
RP   SER-493, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; SER-483 AND SER-493, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; THR-475 AND SER-493, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   INTERACTION WITH PFKFB3, AND PHOSPHORYLATION AT SER-466; THR-468; SER-483;
RP   SER-486 AND SER-493.
RX   PubMed=36402789; DOI=10.1038/s41467-022-34907-0;
RA   McGrail K., Granado-Martinez P., Esteve-Puig R., Garcia-Ortega S., Ding Y.,
RA   Sanchez-Redondo S., Ferrer B., Hernandez-Losa J., Canals F., Manzano A.,
RA   Navarro-Sabate A., Bartrons R., Yanes O., Perez-Alea M., Munoz-Couselo E.,
RA   Garcia-Patos V., Recio J.A.;
RT   "BRAF activation by metabolic stress promotes glycolysis sensitizing
RT   NRASQ61-mutated melanomas to targeted therapy.";
RL   Nat. Commun. 13:7113-7113(2022).
CC   -!- FUNCTION: Synthesis and degradation of fructose 2,6-bisphosphate.
CC       {ECO:0000269|PubMed:11069105}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-fructose 2,6-bisphosphate + H2O = beta-D-fructose 6-
CC         phosphate + phosphate; Xref=Rhea:RHEA:17289, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57634, ChEBI:CHEBI:58579; EC=3.1.3.46;
CC         Evidence={ECO:0000269|PubMed:11069105};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17290;
CC         Evidence={ECO:0000305|PubMed:11069105};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + beta-D-fructose 6-phosphate = ADP + beta-D-fructose 2,6-
CC         bisphosphate + H(+); Xref=Rhea:RHEA:15653, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:57634, ChEBI:CHEBI:58579,
CC         ChEBI:CHEBI:456216; EC=2.7.1.105;
CC         Evidence={ECO:0000269|PubMed:11069105};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15654;
CC         Evidence={ECO:0000269|PubMed:11069105};
CC   -!- ACTIVITY REGULATION: Phosphorylation results in the activation of the
CC       kinase activity. {ECO:0000269|PubMed:11069105}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=57 uM for beta-D-fructose 6-phosphate
CC         {ECO:0000269|PubMed:11069105};
CC         KM=5.1 uM for beta-D-fructose 2,6-bisphosphate
CC         {ECO:0000269|PubMed:11069105};
CC         KM=46 uM for beta-D-fructose 6-phosphate (in presence of AMPK)
CC         {ECO:0000269|PubMed:11069105};
CC         KM=29 uM for beta-D-fructose 6-phosphate (in presence of PKB)
CC         {ECO:0000269|PubMed:11069105};
CC         KM=4.7 uM for beta-D-fructose 2,6-bisphosphate (in presence of AMPK)
CC         {ECO:0000269|PubMed:11069105};
CC   -!- SUBUNIT: Homodimer (By similarity). Forms a heterodimer with PFKFB3
CC       (PubMed:36402789). {ECO:0000250|UniProtKB:Q16875,
CC       ECO:0000269|PubMed:36402789}.
CC   -!- INTERACTION:
CC       O60825; P63104: YWHAZ; NbExp=2; IntAct=EBI-764425, EBI-347088;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60825-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60825-2; Sequence=VSP_004675;
CC   -!- TISSUE SPECIFICITY: Heart.
CC   -!- PTM: Phosphorylation by AMPK stimulates activity.
CC       {ECO:0000269|PubMed:11069105}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the phosphoglycerate
CC       mutase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ005577; CAA06605.1; -; Genomic_DNA.
DR   EMBL; AJ005578; CAA06606.1; -; mRNA.
DR   EMBL; AB044805; BAB19681.1; -; mRNA.
DR   EMBL; AF470623; AAL99386.1; -; mRNA.
DR   EMBL; AK292883; BAF85572.1; -; mRNA.
DR   EMBL; AL445493; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471100; EAW93508.1; -; Genomic_DNA.
DR   EMBL; BC069350; AAH69350.1; -; mRNA.
DR   EMBL; BC069385; AAH69385.1; -; mRNA.
DR   EMBL; BC069583; AAH69583.1; -; mRNA.
DR   EMBL; BC069586; AAH69586.1; -; mRNA.
DR   EMBL; BC069600; AAH69600.1; -; mRNA.
DR   EMBL; BC075075; AAH75075.1; -; mRNA.
DR   EMBL; BC075076; AAH75076.1; -; mRNA.
DR   EMBL; BC112103; AAI12104.1; -; mRNA.
DR   EMBL; BC112105; AAI12106.1; -; mRNA.
DR   CCDS; CCDS31003.1; -. [O60825-2]
DR   CCDS; CCDS31004.1; -. [O60825-1]
DR   RefSeq; NP_001018063.1; NM_001018053.1. [O60825-2]
DR   RefSeq; NP_006203.2; NM_006212.2. [O60825-1]
DR   PDB; 5HTK; X-ray; 2.01 A; A/B=1-505.
DR   PDBsum; 5HTK; -.
DR   AlphaFoldDB; O60825; -.
DR   SMR; O60825; -.
DR   BioGRID; 111229; 57.
DR   ComplexPortal; CPX-1994; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 complex.
DR   IntAct; O60825; 28.
DR   MINT; O60825; -.
DR   STRING; 9606.ENSP00000356047; -.
DR   BindingDB; O60825; -.
DR   ChEMBL; CHEMBL3421525; -.
DR   DEPOD; PFKFB2; -.
DR   GlyGen; O60825; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; O60825; -.
DR   PhosphoSitePlus; O60825; -.
DR   BioMuta; PFKFB2; -.
DR   EPD; O60825; -.
DR   jPOST; O60825; -.
DR   MassIVE; O60825; -.
DR   MaxQB; O60825; -.
DR   PaxDb; O60825; -.
DR   PeptideAtlas; O60825; -.
DR   ProteomicsDB; 49608; -. [O60825-1]
DR   ProteomicsDB; 49609; -. [O60825-2]
DR   Antibodypedia; 34592; 493 antibodies from 36 providers.
DR   DNASU; 5208; -.
DR   Ensembl; ENST00000367079.3; ENSP00000356046.2; ENSG00000123836.15. [O60825-2]
DR   Ensembl; ENST00000367080.8; ENSP00000356047.3; ENSG00000123836.15. [O60825-1]
DR   GeneID; 5208; -.
DR   KEGG; hsa:5208; -.
DR   MANE-Select; ENST00000367080.8; ENSP00000356047.3; NM_006212.2; NP_006203.2.
DR   UCSC; uc001hfg.4; human. [O60825-1]
DR   AGR; HGNC:8873; -.
DR   CTD; 5208; -.
DR   DisGeNET; 5208; -.
DR   GeneCards; PFKFB2; -.
DR   HGNC; HGNC:8873; PFKFB2.
DR   HPA; ENSG00000123836; Tissue enhanced (retina).
DR   MIM; 171835; gene.
DR   neXtProt; NX_O60825; -.
DR   OpenTargets; ENSG00000123836; -.
DR   PharmGKB; PA33212; -.
DR   VEuPathDB; HostDB:ENSG00000123836; -.
DR   eggNOG; KOG0234; Eukaryota.
DR   GeneTree; ENSGT00950000182835; -.
DR   HOGENOM; CLU_006383_1_1_1; -.
DR   InParanoid; O60825; -.
DR   OMA; IACMNGR; -.
DR   OrthoDB; 2013830at2759; -.
DR   PhylomeDB; O60825; -.
DR   TreeFam; TF313541; -.
DR   BioCyc; MetaCyc:HS04690-MON; -.
DR   BRENDA; 2.7.1.105; 2681.
DR   BRENDA; 3.1.3.46; 2681.
DR   PathwayCommons; O60825; -.
DR   Reactome; R-HSA-9634600; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism.
DR   SABIO-RK; O60825; -.
DR   SignaLink; O60825; -.
DR   SIGNOR; O60825; -.
DR   BioGRID-ORCS; 5208; 11 hits in 1170 CRISPR screens.
DR   ChiTaRS; PFKFB2; human.
DR   GeneWiki; PFKFB2; -.
DR   GenomeRNAi; 5208; -.
DR   Pharos; O60825; Tchem.
DR   PRO; PR:O60825; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O60825; protein.
DR   Bgee; ENSG00000123836; Expressed in islet of Langerhans and 185 other tissues.
DR   ExpressionAtlas; O60825; baseline and differential.
DR   Genevisible; O60825; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003873; F:6-phosphofructo-2-kinase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IBA:GO_Central.
DR   GO; GO:0006000; P:fructose metabolic process; TAS:ProtInc.
DR   GO; GO:0006007; P:glucose catabolic process; IEA:Ensembl.
DR   GO; GO:0006096; P:glycolytic process; IDA:UniProtKB.
DR   GO; GO:0006089; P:lactate metabolic process; IEA:Ensembl.
DR   GO; GO:0033133; P:positive regulation of glucokinase activity; IEA:Ensembl.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   CDD; cd07067; HP_PGM_like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 3.40.50.1240; Phosphoglycerate mutase-like; 1.
DR   InterPro; IPR003094; 6Pfruct_kin.
DR   InterPro; IPR013079; 6Phosfructo_kin.
DR   InterPro; IPR013078; His_Pase_superF_clade-1.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001345; PG/BPGM_mutase_AS.
DR   PANTHER; PTHR10606; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; 1.
DR   PANTHER; PTHR10606:SF48; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2; 1.
DR   Pfam; PF01591; 6PF2K; 1.
DR   Pfam; PF00300; His_Phos_1; 1.
DR   PIRSF; PIRSF000709; 6PFK_2-Ptase; 1.
DR   PRINTS; PR00991; 6PFRUCTKNASE.
DR   SMART; SM00855; PGAM; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF53254; Phosphoglycerate mutase-like; 1.
DR   PROSITE; PS00175; PG_MUTASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Hydrolase;
KW   Kinase; Multifunctional enzyme; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..505
FT                   /note="6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
FT                   2"
FT                   /id="PRO_0000179964"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2..248
FT                   /note="6-phosphofructo-2-kinase"
FT   REGION          249..505
FT                   /note="Fructose-2,6-bisphosphatase"
FT   REGION          445..505
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        445..481
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        128
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        158
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        257
FT                   /note="Tele-phosphohistidine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   ACT_SITE        326
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         45..53
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         78
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         102
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         130
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         136
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         167..172
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         172
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         193
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         197
FT                   /ligand="beta-D-fructose 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57634"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         256
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         263
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         269
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         337
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         348..351
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         351
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         355
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         366
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         392..396
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         392
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   BINDING         396
FT                   /ligand="beta-D-fructose 2,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:58579"
FT                   /evidence="ECO:0000250|UniProtKB:P07953"
FT   BINDING         428
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   SITE            256
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   SITE            263
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   SITE            391
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:Q16875"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         29
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         466
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:11069105,
FT                   ECO:0000269|PubMed:36402789, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         468
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:36402789,
FT                   ECO:0007744|PubMed:18669648"
FT   MOD_RES         475
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         483
FT                   /note="Phosphoserine; by BRAF"
FT                   /evidence="ECO:0000269|PubMed:36402789,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231"
FT   MOD_RES         486
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:36402789"
FT   MOD_RES         493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:36402789,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         451..505
FT                   /note="NNFPKNQTPVRMRRNSFTPLSSSNTIRRPRNYSVGSRPLKPLSPLRAQDMQE
FT                   GAD -> AAETTLAVRRRPSAASLMLPC (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11374908,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3"
FT                   /id="VSP_004675"
FT   MUTAGEN         466
FT                   /note="S->E: Constitutively active mutant that cannot be
FT                   phosphorylated and further activated by AMPK."
FT                   /evidence="ECO:0000269|PubMed:11069105"
FT   CONFLICT        28
FT                   /note="Missing (in Ref. 1; CAA06605)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        303..304
FT                   /note="QL -> HV (in Ref. 1; CAA06606)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        372
FT                   /note="R -> L (in Ref. 1; CAA06606)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        396
FT                   /note="R -> H (in Ref. 1; CAA06606)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        406
FT                   /note="G -> D (in Ref. 1; CAA06606)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        427
FT                   /note="A -> T (in Ref. 1; CAA06606)"
FT                   /evidence="ECO:0000305"
FT   STRAND          39..44
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          47..50
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           51..64
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          69..73
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           74..82
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           88..91
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           96..119
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          123..129
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           134..147
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          150..157
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           161..174
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           186..200
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   TURN            206..212
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          215..219
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   TURN            220..223
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          224..228
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           233..242
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          252..256
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           261..265
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           276..292
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          298..301
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           305..312
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           322..324
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           330..332
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           337..343
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           345..353
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   TURN            355..357
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           366..382
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          384..390
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           392..402
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   TURN            407..409
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   HELIX           410..412
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          419..426
FT                   /evidence="ECO:0007829|PDB:5HTK"
FT   STRAND          429..436
FT                   /evidence="ECO:0007829|PDB:5HTK"
SQ   SEQUENCE   505 AA;  58477 MW;  5CD6A933A7EBF604 CRC64;
     MSGASSSEQN NNSYETKTPN LRMSEKKCSW ASYMTNSPTL IVMIGLPARG KTYVSKKLTR
     YLNWIGVPTK VFNLGVYRRE AVKSYKSYDF FRHDNEEAMK IRKQCALVAL EDVKAYLTEE
     NGQIAVFDAT NTTRERRDMI LNFAEQNSFK VFFVESVCDD PDVIAANILE VKVSSPDYPE
     RNRENVMEDF LKRIECYKVT YRPLDPDNYD KDLSFIKVIN VGQRFLVNRV QDYIQSKIVY
     YLMNIHVQPR TIYLCRHGES EFNLLGKIGG DSGLSVRGKQ FAQALRKFLE EQEITDLKVW
     TSQLKRTIQT AESLGVPYEQ WKILNEIDAG VCEEMTYAEI EKRYPEEFAL RDQEKYLYRY
     PGGESYQDLV QRLEPVIMEL ERQGNVLVIS HQAVMRCLLA YFLDKGADEL PYLRCPLHTI
     FKLTPVAYGC KVETIKLNVE AVNTHRDKPT NNFPKNQTPV RMRRNSFTPL SSSNTIRRPR
     NYSVGSRPLK PLSPLRAQDM QEGAD
//
